Evolus (EOLS) Cash & Current Investments (2018 - 2026)

Evolus (EOLS) posted Cash & Current Investments of $49.8 million for Q1 2026, down 7.49% on a QoQ basis from $53.8 million in Q4 2025, and down 26.66% year-over-year from $67.9 million in Q1 2025.

Evolus (EOLS) Cash & Current Investments (2018 - 2026) Analysis & Trends

Evolus' Cash & Current Investments history runs 9 years deep, the most recent figure standing at $49.8 million for Q1 2026.

  • Quarterly Cash & Current Investments fell 26.66% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (down 26.66% YoY) and the FY2025 annual result came in at $53.8 million, down 38.1% from the prior year.
  • Cash & Current Investments was $49.8 million for Q1 2026 at Evolus, down from $53.8 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $106.7 million in Q1 2022 and bottomed at $31.5 million in Q1 2023.
  • A 5-year average of $66.2 million and a median of $62.8 million in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 381.13% — and 2023, when it tumbled 70.5%.
  • Evolus' Cash & Current Investments stood at $53.9 million in 2022, then grew by 16.53% to $62.8 million in 2023, then jumped by 38.37% to $87.0 million in 2024, then slumped by 38.1% to $53.8 million in 2025, then slipped by 7.49% to $49.8 million in 2026.
  • Business Quant data shows EOLS's Cash & Current Investments at $49.8 million in Q1 2026, $53.8 million in Q4 2025, and $43.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 90.13 Bn 88.27 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.08 Bn 20.93 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.38 Bn 18.57 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.80 Bn 16.48 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 428.00 Mn
10 Evolus 399.92 Mn 350.13 Mn 48.90 Mn 49.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49.79 Mn
Dec 31, 2025 53.83 Mn
Sep 30, 2025 43.52 Mn
Jun 30, 2025 61.74 Mn
Mar 31, 2025 67.89 Mn
Dec 31, 2024 86.95 Mn
Sep 30, 2024 85.04 Mn
Jun 30, 2024 93.67 Mn
Mar 31, 2024 96.96 Mn
Dec 31, 2023 62.84 Mn
Sep 30, 2023 38.69 Mn
Jun 30, 2023 41.71 Mn
Mar 31, 2023 31.46 Mn
Dec 31, 2022 53.92 Mn
Sep 30, 2022 65.57 Mn
Jun 30, 2022 84.48 Mn
Mar 31, 2022 106.67 Mn
Dec 31, 2021 146.26 Mn
Sep 30, 2021 107.80 Mn
Jun 30, 2021 131.74 Mn